Introduction
The distal hereditary motor neuropathies (distal HMNs) comprise a clinically and genetically heterogeneous group of disorders predominantly affecting motor neurons in the peripheral nervous system. 1 Affected distal HMN individuals manifest progressive weakness and wasting beginning in the distal muscles of the limbs and have no notable sensory symptoms. Distal HMNs have been classified into seven subgroups based on mode of inheritance, age of onset, distribution of muscle weakness, and clinical progression. 2 Fifteen genetic loci for distal HMN have been mapped, and eight genes have been identified. 3 These encode a functionally diverse array of gene products, including a transfer RNA synthetase, 4 two heat-shock proteins, 5, 6 and a microtubule motor protein involved in axonal transport. 7 A form of distal HMN with linkage to chromosome Xq13.1-q21 (DSMAX; SMAX3 [MIM 300489]) was reported in a Brazilian family. 8 We recently mapped and refined this locus in a second unrelated North American family of European descent. 9 The 14.2 Mb region contained more than 50 annotated genes, including ATP7A (MIM 300011), which encodes a copper-transporting P-type ATPase. 9 Copper is an essential trace metal with potential toxicity and requires exquisite homeostatic control; its regulation involves mechanisms governing gastrointestinal uptake, transport to the developing brain, targeted intracellular delivery to copper enzymes, and hepatic excretion of copper into the biliary tract. [10] [11] [12] [13] These functions are largely fulfilled by a pair of evolutionarily related copper-transporting ATPases, ATP7A and ATP7B (MIM 606882). The ATP7A gene is mutated in Menkes disease (MK; MNK [MIM 309400]), a severe infantile-onset developmental disorder. [14] [15] [16] [17] An allelic variant, occipital horn syndrome (OHS [MIM 304150]), is similar in many clinical and biochemical aspects, although the neurologic phenotype is far less severe. 18, 19 Neither condition features overt motor neuropathy. In this study, we evaluated the ATP7A copper transporter in two families whose affected members had X-linked distal motor neuropathy. and family B (Brazilian) ( Figure 1A ) demonstrated X-linked inheritance of a distal motor neuropathy phenotype ( Figure 1B ) defined by decreased motor action potentials, normal nerve conduction velocities, and limited or no sensory involvement. 1 Both families are of European descent. A total of 31 individuals from family A and 30 individuals from family B were examined for neurological signs. Clinical, biochemical, and electrophysiologic findings in affected members of these families are summarized (Table 1) . The ethics review committees of all participating institutions approved the study, and written informed consent was obtained from subjects or parents of subjects less than 18 years of age.
Mutation Analysis
Genomic DNA was isolated from blood samples using standard protocols or saliva samples using the Oragene Kit (DNA Genotek). Mutation analysis was performed using high resolution melt protocols established in our laboratory. 9 PCR amplicons for mutation scanning were designed to cover the coding exons and flanking intronic sequences. Primers for all genes including the ATP7A Figure 1A ) with the P1386S ATP7A mutation. Both legs showed decreased mass of the vastus lateralis (VL), vastus medialis (VM), tibialis anterior (TA), gastrocnemius (G), and soleus (S) muscles. Both feet showed pes cavus deformities. There was moderate wasting of the first dorsal interosseus (open arrows) and the hypothenar (arrow) muscle groups of the hand. The patient's hair was normal in texture and had no pili torti under light microscopy. The palate showed normal contour. The thorax showed no deformities, and the cardiac and pulmonary examinations were normal. The joints and skin did not show excessive laxity. Radiographic studies showed no wormian bones of the skull, no occipital exostoses, and normal clavicular heads. Plasma catecholamine ratios and the urine concentration of beta-2-microglobulin, biomarkers often elevated in Menkes disease, 22 were normal.
Real-Time Quantitative PCR
Total RNA was isolated using the QIAGEN RNeasy Mini Kit (QIAGEN). cDNA was generated from 5 mg RNA with AffinityScript reverse transcriptase (Stratagene). Quantitative real-time PCR was performed with specific primers for ATP7A (5 0 -GCTACCTTGTCAG ACACGAATGAG-3 0 and 5 0 -TCTTGAACTGGTGTCATCCCTTT-3 0 ) and b-actin (5 0 -GACAGGATGCAGAAGGAGATTACT-3 0 and 5 0 -TG ATCCACATCTGCTGGAAGGT-3 0 ) as previously described. 21 
Immunoblot Analysis
Total cell lysates were denatured by the addition of 53 loading buffer with 5% b-mercaptoethanol (Quality Biological) and heating at 50 C for 10 min. Samples (40 mg total protein) were electrophor- instructions. After membranes were stripped, incubation with a primary mouse anti-b-actin monoclonal antibody conjugated with horseradish peroxidase (Santa Cruz Biotechnology) was performed so that b-actin could be detected; an enhanced chemiluminescence reagent was used for development, as above.
Immunohistochemical Analysis and Confocal Microscopy
Dermal fibroblasts were fixed on glass slides with 4% (w/v) paraformaldehyde. Blocking was performed with 3% (v/v) goat serum at room temperature for 1 hr. Samples were incubated with the rabbit anti-human carboxy-terminal ATP7A primary antibody (described under Immunoblot Analysis) at a dilution of 1:2000 at 4 C overnight; subsequently, Texas Red-labeled anti-rabbit IgG antibody (Molecular Probes) was used as the secondary antibody for incubation at room temperature for 2 hr. Cells were viewed with a confocal microscope (Nikon Eclipse, Nikon), and images captured with Confocal Assistant software.
ATP7A Trafficking
Fibroblasts were grown in duplicate on 12 mm glass coverslips in 24-well trays and cultured at 30 C for 16 hr. The growth media were replaced with either basal media (0.5À1 mM copper) or media supplemented with 200 mM CuCl 2 for 3 hr. Fibroblasts were then fixed with 4% (w/v) paraformaldehyde in PBS for 10 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, and blocked with 1% BSA and 0.25% gelatin in PBS at room temperature 
Yeast Complementation
Site-directed mutagenesis was performed as described 19 T4 DNA ligase and an insert-to-vector ratio of 1.6:1 (35 fmoles: 22 fmoles) were used. The construct generated from this cloning was named del20-23/pYES/sKs (single KpnI site). A 501 bp fragment of the ATP7A cDNA then was excised from del20-23/pYES/ sKs via double digestion with KpnI and ApaI, replaced with a 1201 bp fragment containing the P1386S mutation (C-to-T transition), and named P1386S/pYES/sKs. DNA fidelity was confirmed by automated sequencing. Yeast complementation and timed growth assays were carried out as previously described 19, 22 except that plates and liquid media contained 100 mg/ml blasticidin.
Results

Gene Mutation Analysis
Thirty-three genes that underwent mutation analysis in this study are shown in Figure 2A . High-resolution melt analysis of ATP7A exon 22 showed differential subtractive melt curves between affected male/carrier female and normal male/noncarrier female groups in family A (Figure 2B ). Sequence analysis of nine affected males identified a transition mutation of c.4156C > T in exon 22 ( Figure 2C , family A), which predicts an amino acid substitution of p.P1386S. The alteration was not present in seven unaffected male members from family A. ATP7A was sequenced in ten affected males from family B, and a transition mutation of c.2981C > T in exon 15 was identified ( Figure 2C , family B), predicting a p.T994I amino acid substitution. The alteration was not present in six unaffected males from family B. The p.P1386S and p.T994I, alterations were absent from 800 unrelated, ethnically matched control chromosomes. The documented mutations all occur in the carboxyl half of the ATP7A protein ( Figure 3A ) and are highly conserved ( Figure 3B ).
P1386S ATP7A RNA and Protein Analysis
We used quantitative RT-PCR and immunoblotting to determine whether mRNA and protein levels were altered in P1386S fibroblasts. The level of mRNA expression was not significantly changed ( Figure 4A ), and immunoblot analyses of fibroblast protein extracts ( Figure 4B ) showed a similar amount and size of the protein when these were compared to normal controls.
Immunocytochemical and Biochemical Analyses and Trafficking of P1386S ATP7A Protein
In cultured mammalian cells, ATP7A localizes to the trans Golgi network in basal copper concentrations 22, 23 and relocates to small vesicles and the plasma membrane in cells exposed to elevated copper. 23 Immunocytochemical analyses revealed correct trans Golgi localization of ATP7A in fibroblasts cultured at 37 C under basal copper conditions ( Figure 4C 
in the del ex20-23 fibroblasts from a patient with Menkes disease 22 . Increased copper retention is characteristic of cultured fibroblasts from patients with Menkes disease and occipital horn syndrome, 18 reflecting reduced capacity for copper exodus across the plasma membrane. When we cultured P1386S fibroblasts at 30 C to assess the possibility of a conditional (temperature-sensitive) mutation, 24, 25 we observed impaired ATP7A trafficking in response to copper loading in these P1386S fibroblasts compared to normal fibroblasts ( Figure 4D ). Under basal copper conditions, the wild-type and mutant protein both showed extensive colocalization with the trans Golgi marker p230 ( Figures 4D and 4D h ). After a 3 hr exposure to 200 mM copper, wild-type ATP7A was completely absent from the trans Golgi ( Figure 4D l ) , whereas the P1386S mutant protein remained substantially colocalized with the trans Golgi marker ( Figure 4D p ) . To confirm this observation, we scored 48 cells for the presence of ATP7A in the trans Golgi after copper exposure. This semiquantitative evaluation indicated that 24/27 (89%) P1386S cells retained ATP7A in the trans Golgi, as compared to 3/21 (14%) normal control cells (p < 0.0001). We also confirmed the presence of this trafficking abnormality in cultured T994I fibroblasts ( Figure S1 ), which represents a delay in the expected movement of ATP7A-laden vesicles from the trans Golgi network to the plasma membrane after copper exposure.
Yeast Complementation Studies
We also employed a yeast complementation assay 19, 22 to assess the capacity of the P1386S mutant allele to complement an S. cerevisiae copper-transport knockout, ccc2D. This assay measures the capacity of human ATP7A to replace the function normally performed by the ATP7A ortholog ccc2; specifically, this function is the delivery of copper to Fet3, a copper-containing protein required for high-affinity iron uptake. 26 On copper-and iron-deficient solid media, the P1386S allele complemented ccc2D at 22 , 25 , 30 , and 37 C, whereas the ATP7A deletion allele, del ex20-23, did not (data not shown). To quantify the relative amount of residual copper-transport activity, we utilized a standard timed growth assay 19, 22, [27] [28] [29] in copperand iron-deficient liquid media at the four temperatures.
The growth of ccc2D transformed with the P1386S allele was less than wild-type growth at all temperatures (Figure 5) . At 30 C, the standard optimal temperature for yeast cell growth, the calculated copper-transport capacity of P1386S in ccc2D during exponential phase growth was 70% relative to that in ccc2D transformed by the wildtype ATP7A ( Figure 5C ). There was no further diminution in P1386S residual functional activity relative to the wildtype when the assay was performed at lower temperatures (22 C and 25 C, Figures 5A and 5B). As expected, ccc2D High-resolution melt analysis was used for scanning all genes except for HDAC8, RLIM, and PGAM4, which underwent sequence analysis. 9 (B) Subtractive difference plot for affected/carrier and normal/noncarrier samples in family A for exon 22 of ATP7A. The differential shape and grouping of affected/carrier and normal/noncarrier difference plots suggested that a DNA variant was segregating with the distal motor neuropathy phenotype in this family.
(C) Sequence data in affected males, carrier females, and normal males for p.P1386S and p.T994I. An asterisk denotes the base change resulting in missense mutations that segregate with distal motor neuropathy in the respective families. The GenBank sequences NM_00052 and NP_000043.3 were used as the reference sequences for the ATP7A cDNA and the ATP7A protein, respectively. Mutations are designated on the basis of numbering of the A in the ATG translation initiation site as þ1.
transformed with the del ex20-23 ATP7A allele ( Figure 5 , orange lines and triangles) grew poorly in the timed growth assay at all temperatures.
Discussion
Our findings reveal a third clinical phenotype associated with mutations in the ATP7A copper transporter gene, which was shown previously to cause Menkes disease [14] [15] [16] and occipital horn syndrome. 18 This new allelic variant involves progressive distal motor neuropathy with minimal or no sensory symptoms. Affected patients with the distal motor neuropathy discussed here do not manifest the severe infantile central neurological deficits observed in Menkes disease, the signs of autonomic dysfunction seen in occipital horn syndrome, the hair and connective-tissue abnormalities found in both conditions, or any of the clinical biochemical features of those well-characterized phenotypes. [17] [18] [19] 22 These findings highlight the phenotypic distinction between this isolated distal motor neuropathy and the syndromes previously associated with ATP7A mutations. By comparison of the molecular bases, Menkes disease is caused by profound loss-of-function mutations, including deletions, splice-site mutations at canonical positions, nonsense mutations, and missense mutations that affect a critical functional domain in ATP7A or induce misfolding, [14] [15] [16] 25, 28, 30 whereas occipital horn syndrome is associated with molecular defects that allow considerable residual copper transport, often via leaky splice-junction mutations involving noncanonical bases. 18, 19, 30 In contrast, the missense mutations we describe here do not disrupt critical functional domains, disturb proper splicing, or cause reduced levels of ATP7A protein ( Figure 4B ). They occur in exons 15 (p.T994I) and 22 (p.P1386S), locations in which ATP7A missense mutations appear to be exceedingly rare. 30 The phenomenon of late, often adult-onset, distal muscular atrophy implies that these mutations produce somewhat attenuated effects that require years to provoke pathological consequences. The aberrant ATP7A trafficking in P1386S and T994I fibroblasts, the copper-retention phenotype in P1386S fibroblasts that is intermediate between normal and classical Menkes disease, and the partial complementation of the ccc2D copper-transport knockout by the P1386S allele are all consistent with this hypothesis. It is known that individuals with acquired copper deficiency due to excess zinc ingestion, malabsorption, gastric bypass surgery, or nephrotic syndrome can develop myeloneuropathy involving a profound sensory ataxia that improves or stabilizes in response to copper repletion. [31] [32] [33] [34] [35] Signs of lower motor-neuron disease, including proximal and distal muscle weakness and bilateral foot drops, have also been reported in copper-deficient individuals. 36 Taken together with these reports, our molecular, clinical, and biochemical findings suggest that motor neurons might be particularly sensitive to perturbations in copper homeostasis.
The precise nature of such perturbations remains to be elucidated. The abnormal trafficking of mutant ATP7A in fibroblasts at 30 C raises the possibility that these variants represent a new class of cold-sensitive mutations, although clinical evidence of thermal sensitivity is not overtly apparent in affected individuals from these families. 8, 9 A previously studied temperature-sensitive ATP7A missense mutation involved abnormal intracellular localization due to protein misfolding, which was ameliorated at a lower temperature (30 C). 25 Because the P1386S and T994I trafficking defect is clearly not improved at lower temperatures ( Figure 4D and S1), protein misfolding seems unlikely to explain the impact of these two mutations. The absence of dramatic temperature effects in the yeast complementation experiments is not surprising because proper trafficking is not required for metalation of Fet3p, the capacity for which is measured by this assay. 26 Our results revealed a modest loss of copper-transport function (70% of wild-type) in this process for P1386S ( Figure 5C ). We speculate that reduced conformational flexibility in P1386S and T994I ATP7A impedes normal trafficking of the protein and impairs copper transport into the secretory pathway for incorporation into nascent cuproproteins. Superoxide dismutase 1 (MIM 147450), cytochrome c oxidase (MIM 516030), dopamine-beta-hydroxylase (MIM 609312), and peptidyl-amidating monooxygenase (MIM 170270) are cuproenzymes highly relevant to neurological function. 37 Although gain-of-function missense mutations in superoxide dismutase 1 are implicated in a familial form of amyotrophic lateral sclerosis involving upper as well as lower motor-neuron degeneration, 38 the ATP7A mutations we report presumably would reduce, rather than exaggerate, activity of this enzyme. Even slightly subnormal activities of certain copper enzymes might contribute to distal motor neuropathy. For example, chronic mild deficiency of cytochrome c oxidase, an inner mitochondrial membrane enzyme containing two subunits that bind copper, 39 could gradually induce mitochondrial dysfunction in motor neurons. 40 The requirement for ATP7A in normal axonal outgrowth and synaptogenesis has recently been recognized. 41 Anterograde axonal ATP7A trafficking is induced by activation of the N-methyl-D-aspartate receptor that binds glutamate and might be associated with synaptic release of copper. 42 Thus, possible alternative mechanisms for the distal motor neuropathy in our patients include impaired axonal trafficking, glutamate-mediated excitotoxicity, and altered synaptic activity of ATP7A. Because the axons and synapses of distal motor neurons extend a considerable distance from their cell bodies in the spinal cord, we speculate that these neuronal elements might be autonomous from their cell bodies in terms of requirements for ATP7A. The presence of intracellular protein aggregates has been described in many neurodegenerative diseases, 37, 38 and abnormal inclusions have been defined for heterogeneous forms of inherited distal motor neuropathy, typically , cell densities (OD600) of shaking liquid cultures were measured at 0, 2, 4, and 6 hr for the Saccharomyces cerevisiae copper transport mutant, ccc2D transformed with the wild-type (WT) ATP7A allele (blue), or ATP7A alleles harboring P1386S (red), a deletion of the ATP7A carboxyl-terminal four exons, del 20-23 (orange), and nontransformed ccc2D (green). Error bars denote 51 standard deviation from the mean of quadruplicate OD600 measurements. The growth of ccc2D transformed with the P1386S allele was less than that of ccc2D transformed with the wild-type allele at all temperatures tested. Growth of these two yeast transformants was suboptimal at 22 C, 25 C, and 37 C compared to 30 C. At 30 C, P1386S complemented the ccc2D knockout strain at 70% of the wild-type rate. Residual copper transport was estimated from cell density at time points during exponential-phase growth (4 hr and 6 hr). Ccc2D transformed with the deletion allele (orange) and nontransformed ccc2D (green) grew poorly at all temperatures.
identified when mutant proteins were overexpressed in mammalian cells. 6, 7, [43] [44] [45] It will be useful to formally exclude or confirm such effects for the ATP7A mutations we report here. The spectrum of genes implicated in the causation of distal motor neuropathy illustrates the diverse processes involved in motor neuron physiology. [4] [5] [6] [7] 43, 46 The identification of mutations in a gene essential to the homeostasis of trace metals reveals a new component in this system and further highlights the critical role of copper metabolism in neurodegeneration. 37 Studies that explore and clarify the potential mechanisms suggested by our findings are warranted and might have relevance to other forms of motor-neuron disease, including amyotrophic lateral sclerosis. Insights concerning the functions of ATP7A in motor neurons might lead to the development of rational treatments for this newly discovered form of X-linked distal motor neuropathy and other related disorders in which copper metabolism plays a previously under-appreciated role.
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